文献速递血液透析通路

血液透析患者大多数复杂的头臂静脉闭塞可在诊室血管造影室用简单血管内技术治疗

Most complex brachiocephalic vein occlusion in hemodialysis patients can be treated with simple endovascular techniques in an office-based angiosuite.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-03-31

该研究报道2009年1月至2022年1月115例血液透析患者接受头臂静脉血管内再通,其中73例初始手术在诊室血管造影室完成。多数闭塞可用标准导管导丝或经间隔针等简单技术再通,手术成功率99.1%,无术中并发症,结论认为简单血管内技术安全可行且结果持久。

要点

  • 115例血液透析患者头臂静脉闭塞再通,92.1%用标准导管导丝完成,7.8%用经间隔针。
  • 手术成功率99.1%,无术中并发症,92例既往臂部通路全部维持有效使用。
  • 中位一期通畅9.6个月,中位一期辅助通畅56.2个月,80个月二期通畅率75%。

核心结论

  • 头臂静脉闭塞的血管内再通可在诊室环境下用简单血管内技术安全完成,并发症轻微且结果持久。

研究设计与样本

  • 单中心回顾性研究,纳入2009年1月至2022年1月115例接受头臂静脉血管内再通的血液透析患者,其中73例初始手术在诊室血管造影室完成。

主要发现

  • 中位年龄62岁(范围23-91岁),女性占56%,糖尿病61%,高血压68%。
  • 56例(48.7%)表现为与既往功能通路同侧的重度上肢水肿。
  • 用标准导管导丝再通106例(92.1%),用经间隔针9例(7.8%),其中7例采用由内向外技术。
  • 头臂静脉狭窄初始治疗为单纯经皮腔内球囊血管成形术74例(64.3%)、支架33例(28.7%)、HeRO导管8例(7%),其他中心静脉病变治疗49例(42.6%)。
  • 手术成功99.1%,无术中并发症;92例既往臂部通路全部维持有效使用(100%),23例中22例(95.6%)成功新建上肢通路;总体临床成功率92%。

关键数值与推荐

  • 中位术后监测23个月,中位12个月,范围1-84个月。
  • 监测期间需266次血管内手术维持通路功能,91%在诊室、9%在医院完成。
  • 最终49例(42.6%)置入支架,11例(9.56%)感染,6例需完全移除通路。
  • 通路失败其他原因包括2例中心静脉血栓和1例大面积肺栓塞,最终9例(7.8%)通路失败。
  • 随访期间32例(27.8%)死于无关原因,76例(66%)维持功能通路。

临床怎么用

  • 原文结论认为头臂静脉闭塞的血管内再通可在诊室环境下用简单血管内技术安全完成,并发症轻微且结果持久。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Brachiocephalic vein (BCV) obstruction can cause dialysis access dysfunction and failure. Central vein stenosis involving the BCV may require advanced endovascular procedures. We report that most BCV occlusions can be treated using simple endovascular techniques on an outpatient basis. METHODS: From January 2009 to January 2022, 115 hemodialysis patients underwent BCV endovascular revascularization. Seventy-three of the initial procedures were performed in an office-based angiosuite. Indications for the procedure were BCV occlusion endangering the performance of a previous arm access or making the creation of a new arm access unadvisable. We recorded and analyzed risk factors and procedural results, patency rates, complications, and mortality. RESULTS: The median age was 62 years (range, 23-91 years); 56% were female. Most prevalent associated conditions were diabetes mellitus (61%) and hypertension (68%). Fifty-six patients (48.7%) presented with severe upper extremity edema ipsilateral to the side of pre-existing functioning access. Obstruction recanalization was effective using standard catheter and wire in 106 cases (92.1%) and transseptal needle in nine cases (7.8%), that included seven using inside-out procedure. Initial management of the BCV stenosis was percutaneous transluminal balloon angioplasty alone in 74 patients (64.3%), stenting in 33 (28.7%), and HeRO conduit in eight cases (7%). Treatment of other central venous lesions included 49 cases (42.6%). The procedure was successful in 99.1% of patients. No intraoperative complications occurred. All 92 patients with previous arm access maintained adequate performance (100%). In 22 of 23 patients (95.6%), new upper extremity access creation was effectively performed after the venous intervention. Overall clinical success rate was 92%. The mean postoperative monitoring was 23 months, the median was 12 months, and the range was 1 to 84 months. During this monitoring period, 266 endovascular procedures, 91% in the office and 9% in the hospital, were required to preserve access performance. Eventually, 49 patients (42.6%) were stented. Eleven patients (9.56%) had infections, and six required complete access removal. Other causes of access failure included two patients with central vein thrombosis and one with massive pulmonary embolus. At the end, nine patients (7.8%) had access failure. Thirty-two patients (27.8%) died of unrelated causes during the follow-up period. Seventy-six patients (66%) have maintained functional access. Kaplan-Meier curves determined median primary patency of 9.6 months, median primary assisted patency of 56.2 months, and secondary patency of 75% at 80 months. CONCLUSIONS: Successful endovascular revascularization of BCV obstruction can be treated safely, with simple endovascular techniques in an office-based context with minor complication rates and durable results.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Uceda PV, Ahn SS. Most complex brachiocephalic vein occlusion in hemodialysis patients can be treated with simple endovascular techniques in an office-based angiosuite. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37003464. doi:10.1016/j.jvsv.2023.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。